Tag: CBT > Cannabidiol Schedule

Cannabis Rescheduling

2 Senate Democrats Press Likely DEA Head on Cannabis Rescheduling Stance

Terry Cole, Trump’s nominee to lead the Drug Enforcement Administration, said he would provide 'careful consideration' to the rescheduling matter.

May 14, 2025

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

International

Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty

The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty.

February 22, 2024

Interviews & Opinion

Study Shows Two-Thirds of American Adults Support Biden’s Cannabis Policy Reform Plan

The poll found that nearly three-quarters of respondents support changing how cannabis is classified under federal law and removing it as a Schedule I drug.

October 21, 2022

Adult-Use Legalization Bill

Congressional Committee Hearing Navigates the Catch-22 of Cannabis Research

The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.

January 17, 2020

Finance

RE Botanicals, Palmetto Harmony Merge as Vertically Integrated Hemp/CBD Company

The merger brings together like-minded entrepreneurs in a rapidly consolidating marketplace.

August 22, 2019